We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genetic Variation Reduces Efficacy of Tamoxifen for Some Women
Genetic Variation Reduces Efficacy of Tamoxifen for Some Women
December 16, 2005
Breast cancer drug tamoxifen may not be as effective in women with a genetic trait that lowers levels of an enzyme necessary to activate the drug, according to a study by University of Michigan and Mayo Clinic researchers.